Australia has wasted valuable resources and time by funding fragmented pieces of research into COVID-19, rather than taking a strategic, national approach to establishing clinical trials of potential treatments, leading researchers claim. The Federal Department of Health has defended its grant-based funding model for COVID-19 research, despite criticism from some respected respiratory and pharmacology researchers ...
Australia has “taken eye off the ball” on COVID research, respiratory experts say
By Megan Howe
18 Aug 2020